Suppr超能文献

1996 - 2000年美国未破裂颅内动脉瘤血管内治疗后的院内发病率和死亡率:医院及医生手术量的影响

In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume.

作者信息

Hoh Brian L, Rabinov James D, Pryor Johnny C, Carter Bob S, Barker Fred G

机构信息

Neurosurgical Service, Massachusetts General Hospital, Boston, MA 02114, USA.

出版信息

AJNR Am J Neuroradiol. 2003 Aug;24(7):1409-20.

Abstract

BACKGROUND AND PURPOSE

Endovascular therapy is increasingly being used for the treatment of unruptured intracranial aneurysms. Our purpose was to determine the risk of adverse outcomes after contemporary endovascular treatment of unruptured intracranial aneurysms in the United States. Patient, treating physician, and hospital characteristics were tested as potential outcome predictors, with particular attention paid to volume of care.

METHODS

We conducted a retrospective cohort study by using the Nationwide Inpatient Sample, 1996-2000. Multivariate logistic and ordinal regressions were used with end points of mortality, discharge other than to home, length of stay, and total hospital charges.

RESULTS

Four hundred twenty-one patients underwent endovascular treatment at 81 hospitals. The in-hospital mortality rate was 1.7%, and 7.6% were discharged to institutions other than home. Analysis was adjusted for age, sex, race, primary payer, year of treatment, and four variables measuring acuity of treatment and medical comorbidity. Median annual number of unruptured aneurysms treated was nine per hospital and three per treating physician. Higher volume hospitals had fewer adverse outcomes; discharge other than to home occurred after 5.2% of operations at high volume hospitals (>23 admissions per year) compared with 17.6% at low volume hospitals (fewer than four admissions per year) (P<.001). Higher physician volume had a similar effect (0% versus 16.4%, P=.03). The mortality rate was lower at high volume hospitals (1.0% versus 3.7%) but not significantly so. At high volume hospitals, length of stay was shorter (P<.001) and total hospital charges were lower (P<.001).

CONCLUSION

For patients with unruptured aneurysms treated in the United States from 1996 to 2000, endovascular treatment at high volume institutions or by high volume physicians was associated with significantly lower morbidity rates and modestly lower mortality rates. Length of stay was shorter and total hospital charges lower at high volume centers.

摘要

背景与目的

血管内治疗越来越多地用于未破裂颅内动脉瘤的治疗。我们的目的是确定在美国对未破裂颅内动脉瘤进行当代血管内治疗后不良后果的风险。对患者、治疗医师和医院特征作为潜在结局预测因素进行了测试,特别关注治疗量。

方法

我们使用1996 - 2000年全国住院患者样本进行了一项回顾性队列研究。使用多变量逻辑回归和有序回归,以死亡率、非回家出院、住院时间和总住院费用作为终点。

结果

81家医院的421例患者接受了血管内治疗。院内死亡率为1.7%,7.6%的患者出院时未回家而是前往其他机构。分析对年龄、性别、种族、主要支付方、治疗年份以及四个衡量治疗敏锐度和医疗合并症的变量进行了调整。每家医院每年治疗未破裂动脉瘤的中位数为9例,每位治疗医师每年治疗3例。治疗量较高的医院不良后果较少;高治疗量医院(每年入院>23例)5.2%的手术患者出现非回家出院,而低治疗量医院(每年入院少于4例)这一比例为17.6%(P<0.001)。医师治疗量较高也有类似效果(0%对16.4%,P = 0.03)。高治疗量医院的死亡率较低(1.0%对3.7%),但差异无统计学意义。在高治疗量医院,住院时间较短(P<0.001),总住院费用较低(P<0.001)。

结论

对于1996年至2000年在美国接受治疗的未破裂动脉瘤患者,在高治疗量机构或由高治疗量医师进行血管内治疗与显著较低的发病率和适度较低的死亡率相关。高治疗量中心的住院时间较短,总住院费用较低。

相似文献

4
The emergence of endovascular treatment-only centers for treatment of intracranial aneurysms in the United States.
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e504-10. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.024. Epub 2013 Jun 28.
7
Treatment of ruptured and unruptured cerebral aneurysms in the USA: a paradigm shift.
J Neurointerv Surg. 2018 Jul;10(Suppl 1):i69-i76. doi: 10.1136/jnis.2011.004978.rep.
8
Use of endovascular coil embolization and surgical clip occlusion for cerebral artery aneurysms.
J Neurosurg. 2007 Sep;107(3):530-5. doi: 10.3171/JNS-07/09/0530.
10
Treatment of unruptured cerebral aneurysms in California.
Stroke. 2001 Mar;32(3):597-605. doi: 10.1161/01.str.32.3.597.

引用本文的文献

4
5
Association between volume of surgery for acute hemorrhagic stroke and mortality.
Medicine (Baltimore). 2018 Aug;97(35):e12105. doi: 10.1097/MD.0000000000012105.
6
Association between insurance status and patient safety in the lumbar spine fusion population.
Spine J. 2017 Mar;17(3):338-345. doi: 10.1016/j.spinee.2016.10.005. Epub 2016 Oct 17.
7
Disparities in reportable quality metrics by insurance status in the primary spine neoplasm population.
Spine J. 2017 Feb;17(2):244-251. doi: 10.1016/j.spinee.2016.09.010. Epub 2016 Sep 21.
8
Insurance status and reportable quality metrics in the cervical spine fusion population.
Spine J. 2017 Jan;17(1):62-69. doi: 10.1016/j.spinee.2016.08.005. Epub 2016 Aug 4.
9
Medicare expenditures for elderly patients undergoing surgical clipping or endovascular intervention for subarachnoid hemorrhage.
J Neurosurg. 2017 Mar;126(3):805-810. doi: 10.3171/2016.2.JNS152994. Epub 2016 May 20.
10
Medicare expenditures for elderly patients undergoing surgical clipping or endovascular intervention for unruptured cerebral aneurysms.
J Neurointerv Surg. 2017 Mar;9(3):324-328. doi: 10.1136/neurintsurg-2016-012313. Epub 2016 Mar 24.

本文引用的文献

2
Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals.
Stroke. 2002 Jul;33(7):1851-6. doi: 10.1161/01.str.0000019126.43079.7b.
3
The healthcare cost and utilization project: an overview.
Eff Clin Pract. 2002 May-Jun;5(3):143-51.
4
6
Endovascular treatment of unruptured intracranial aneurysms.
AJNR Am J Neuroradiol. 2002 May;23(5):756-61.
7
Hospital volume and surgical mortality in the United States.
N Engl J Med. 2002 Apr 11;346(15):1128-37. doi: 10.1056/NEJMsa012337.
8
Blood use in cerebrovascular neurosurgery.
Stroke. 2002 Apr;33(4):994-7. doi: 10.1161/hs0402.105296.
9
Endovascular management of unruptured intracranial aneurysms: does outcome justify treatment?
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):485-90. doi: 10.1136/jnnp.72.4.485.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验